NewsCura

The Keepers Holdings, Inc.

Disclaimer: The research and recommendation below were generated by Claude Fable. Please treat this as one input for your own research — not as the sole basis for any decision to buy or sell a stock.

Last checked
Price
1.9200
Trading status
Normal
Recommendation
Buy (7.6x with a third of market cap in cash; brand concentration)Buy
Committee call
Buy
Indices
MidCap

Analysis

KEEPR - The Keepers Holdings, Inc.

One-line summary: a genuinely net-cash, growing spirits distributor trading under 8x trailing earnings, but the growth rides on one imported brandy brand and the whole structure sits inside Lucio Co's family orbit.

Snapshot
Reviewed July 19, 2026
Index membership PSE MidCap
Price at review P1.92
Recommendation Buy (deep value, real net cash; single-brand concentration and family control cap conviction)
Market cap ~P27.86B (14.51B shares)
Trailing P/E (TTM) ~7.56x
Estimated forward P/E Not covered by sell-side analysts; no published estimate found
Dividend (2025, paid 2026) P0.12/share, ~6.25% yield at P1.92 (payout ratio ~47% of 2025 earnings)
P/B ~1.52x
Debt Negligible (D/E ~0.01-0.02; total debt ~P240-281M against ~P18-19B equity)

Core business and single-brand concentration

The Keepers Holdings is the holding company Cosco Capital carved out in 2021 to house Lucio Co's imported spirits distribution business: Montosco, Meritus Prime Distributions, Premier Wine & Spirits, and Fertuna Distributions. Per IWSR Drinks Market Analysis, KEEPR was the leading distributor of imported spirits in the Philippines as of 2020, with 74.0% volume share and 66.9% value share.

The catch: Alfonso brandy alone accounts for 60% of distributor revenue. That is not a diversified portfolio, it is one brand with a long tail of smaller lines (Fundador brandy distribution, assorted whiskies, wines, and beers) around it. Keepers moved to protect that single revenue source in September 2022 by buying 50% of Bodegas Williams & Humbert (BWH), Alfonso's Spanish producer, locking in supply but also tying the company's fortunes to one factory in Jerez and one currency (euro input costs against peso sales). A supply disruption, a BWH-level dispute, or a shift in Filipino drinking preference away from brandy would hit this company far harder than a diversified beverage group.

Revenue and earnings trend

Revenue: P11.0B (2021), P14.0B (2022), P16.3B (2023), P18.5B (2024), P20.2B (2025), with TTM through Q1 2026 at P20.4B. Net income: P1.58B (2021), P2.24B (2022), P2.92B (2023), P3.54B (2024), P3.57B (2025), TTM P3.69B. Growth has been real, not election-cycle or one-off driven: 2025 revenue grew 9% on an 8% rise in cases sold, credited to premiumization (Filipinos trading up within brandy) and the continued recovery of on-premise drinking (bars, restaurants) after the pandemic. Q1 2026 kept the pattern going: revenue P4.31B (+6.1%), net income P811.4M (+18%).

One flag: net income grew only 0.8% in 2025 even as revenue grew 9%, and operating income actually fell about 3.1% for the year. That gap between top-line growth and bottom-line growth points to margin compression, likely input costs (imported spirits priced in foreign currency) or competitive pricing pressure, with the income statement's modest net income growth propped up partly by non-operating items (plausibly interest income off the company's own cash pile) rather than the core distribution business alone.

Net cash position versus market cap

This is the strongest part of the thesis. Balance sheet cash and equivalents were P3.85B at end-2025 and P4.28B at Q1 2026, but the company also holds P4.58-4.97B in short-term investments (time deposits/money-market instruments) alongside that cash. Combined cash and short-term investments: P8.43B (FY2025) rising to P9.25B (Q1 2026), against total debt of only P240-281M. Net cash (cash plus short-term investments, less debt) works out to roughly P8.15B (FY2025) to P9.0B (Q1 2026), or about P0.56-0.62 per share, against a P1.86 share price. That is 30-33% of the entire market cap sitting in cash and near-cash instruments, before counting a further P5.96-6.06B in long-term investments on top. Strip the net cash out and the operating business trades at roughly 5x trailing earnings, cheap even by the standards of this deep-value screen.

Dividend sustainability

Dividend per share: P0.024 (2022 declaration), P0.054 (2023), P0.077 (Dec 2023 ex-date), P0.10 (2024), P0.12 (2025 earnings, paid May 2026), a clean multi-year uptrend. The board explicitly raised the regular payout ratio to 50% of 2025 net income (up from a lower ratio previously), a policy move rather than a one-off. Free cash flow easily covers it: FCF and dividends paid have never been close to a shortfall in the years with positive operating cash flow, and the enormous net cash buffer means even a weak year would not force a cut. The main dividend risk is not coverage, it is that the payout could be redirected toward a related-party acquisition instead of returned to shareholders (see Capital allocation below).

ROE

ROE: 17.11% (2021), 17.51% (2022), 20.26% (2023), 21.65% (2024), 19.47% (2025). Genuinely healthy and, unlike some of the highly leveraged or thin-equity names on this list, not flattered by debt: D/E has stayed near 0.01-0.02 throughout. A company earning 17-22% on equity while carrying almost no debt and holding a third of its market cap in cash is a quality profile, not just a statistical illusion.

Free cash flow

Operating cash flow: P1.37B (2021), P1.70B (2022), -P0.09B (2023), P4.63B (2024), P5.28B (2025). Capex is trivial in this distribution business (P7-16M a year), so free cash flow tracks operating cash flow almost one for one. The 2023 negative operating cash flow is the one anomaly worth flagging: it coincided with the BWH integration and a period of working-capital build (inventory, receivables) rather than a profit problem, since net income that year was actually up 30% to P2.92B. The 2024-2025 jump to P4.6-5.3B in OCF is the more representative run rate for a business of this size, though investors should watch whether working-capital swings like 2023 recur.

Cosco Capital, controlled by Lucio Co and family, carved KEEPR out of its liquor distribution assets via a March 2021 share swap (Montosco, Meritus, Premier for KEEPR shares), then took it public in November 2021 at P1.50/share. The Co family and Cosco retain roughly 79% of KEEPR, with public float around 20-21%, a thin float similar in spirit (though not degree) to EMI's liquidity problem. Every major strategic move so far has run through the same family: the BWH stake was bought to protect the Alfonso supply chain that Cosco's group depends on, and Cosco itself (Puregold, the broader retail empire) is both KEEPR's largest shareholder and, plausibly, one of its retail distribution partners. None of the sourcing found explicit disclosure of related-party sales terms or pricing, which itself is a governance gap worth flagging: a minority shareholder has to trust that transactions between KEEPR and its Cosco/Puregold siblings are priced at arm's length. With ~P8-9B in net cash and rising, the capital-allocation question that matters most going forward is whether that pile gets returned to all shareholders (the current path, via the 50% payout policy) or gets deployed into another Co-family-adjacent acquisition on terms outside investors' view.

The broader Philippine consumer spending backdrop has been soft. Visa's discretionary spending index stayed below the 100 expansion threshold through Q1 2026, and Emperador (EMI), the world's largest brandy producer and KEEPR's closest read-across, has openly cited a market "inundated with cheap products as consumers seek for value" while its net income has fallen roughly 61% since its 2022 peak. Against that backdrop, KEEPR's 2025-2026 growth (revenue +9% in 2025, net income +18% in Q1 2026) looks like an outlier, credited to premiumization within its Alfonso franchise and on-premise recovery rather than a rising tide lifting all spirits names. That divergence should be treated with some skepticism: it may reflect real brand strength, or it may just mean the weak-consumer story has not yet reached KEEPR's more premium price point the way it has hit EMI's mass-market brandy.

Cross-sector context: EMI trades at roughly 62x trailing earnings on a shrinking-profit business, a controlling family holding near 80% of shares, and a dividend cut three years running, a clear Sell in this tracker. Ginebra San Miguel (GSMI), the mass-market gin maker under the Cojuangco/San Miguel side of the industry (reviewed separately, in parallel with this page), sits in a more economically sensitive part of the same PH spirits sector: gin is a lower price point than imported brandy and typically more exposed to a weak-consumer environment. KEEPR, by contrast, is the cheapest of the three on trailing earnings (~7.3x) and the only one with a genuine, large net cash position rather than debt-funded capacity, but it shares the same structural issue as EMI: a single controlling family (79% here versus EMI's ~79% Tan/AGI stake) and thin public float.

Verdict at P1.92 (July 19, 2026)

Buy, with real caveats. A week on from the last review, the price has drifted up about 3% (P1.86 to P1.92) but nothing fundamental has changed: no new quarterly results have been posted (the next print is still due August 13, 2026), no fresh dividend has been declared, and no news has surfaced on the Alfonso brand, the BWH stake, or the Cosco/Puregold related-party question. None of the buy or sell triggers below have fired.

The valuation case is still straightforward, just marginally less cheap than a week ago: ~7.56x trailing earnings (up from ~7.3x), 17-22% ROE with almost no leverage, a growing and cash-covered dividend near 6.25%, and roughly a third of the market cap sitting in cash and short-term investments (before counting further long-term investments). Strip out the net cash and the core distribution business is priced a little above 5x earnings, still cheap for a company with genuine volume and premiumization growth, not a cyclical peak.

The caveats keep this from being an unqualified buy. Alfonso brandy alone is 60% of distributor revenue, a single-category concentration that makes this a bet on one brand's continued premiumization rather than a diversified beverage portfolio. The Co family controls roughly 79% of the shares through Cosco Capital, public float is thin (~20-21%), and every major capital move (the BWH stake, the original share-swap formation) has run through related parties without full visibility into pricing terms. The stock has also barely moved from its P1.50 IPO price five years ago (November 2021) despite net income more than doubling over that period, a sign the market has never fully re-rated it, which cuts both ways: it could mean the market knows something about durability that the earnings trend does not yet show, or it could mean the re-rating is still ahead.

What would change the call:

  • Buy trigger (add to a position): net cash keeps building without a value-destructive related-party acquisition, Alfonso volume growth continues at a mid-to-high single digit pace for another 2 full years, or the market starts pricing the net-cash pile explicitly (P/B moving below 1.2x while ROE stays above 15%).
  • Sell trigger: Alfonso brandy volumes decline for two consecutive quarters, KEEPR's net cash gets deployed into a related-party transaction on terms not disclosed at arm's length, the dividend payout ratio policy gets reversed downward, or operating margin compression (like the 3.1% operating income decline in 2025 despite 9% revenue growth) continues for another full year.

PSE MidCap names carry lighter trading volume than PSEi blue chips, and a ~79% family-held float compounds that illiquidity.

Committee review (July 19, 2026)

Five investor lenses judged this page's facts independently, each confined to its own framework. No fundamental data has changed since the July 12, 2026 run (no new quarterly print, no dividend action, no related-party news), only the price (P1.86 to P1.92), so each lens re-examined the same facts rather than reacting to new information.

Lens Signal Confidence Core argument
Ben Graham Bullish 76 Graham's own screen (P/E x P/B) now comes in near 11.5, up slightly from 10.7 last week but still well inside his 22.5 ceiling, and senior claims are almost nonexistent (D/E 0.01-0.02) against cash and investments of roughly P14.4-15.3B. Five years of unlevered, growing earnings (net income P1.58B to P3.57B, ROE 17-22%) still supports trusting a price this cheap against cash and book.
Warren Buffett Bullish 61 ROE has held 17-21.65% for five straight years without leverage, and owner earnings look better than reported net income since capex is trivial against P5.28B of 2025 operating cash flow. The multi-year Alfonso run still reads as durable pricing power, but the 79% family stake with undisclosed related-party terms and 2025's margin compression (operating income -3.1%) keep this from high conviction.
Michael Burry Bullish 60 Paying a little over 5x earnings for the operating business once net cash is stripped out, next to a peer (EMI) at 62x with shrinking profits, is still the balance-sheet mispricing he looks for. Nothing has moved the 2025 margin-compression question either way; Q1 2026's reacceleration (net income +18%) still argues it's a one-year wobble, not structural rot, pending the August 13 print.
Nassim Taleb Bullish 59 Zero refinancing risk (D/E 0.01-0.02, trivial debt) and a self-funding business (P5.28B operating cash flow against P7-16M capex) remain the opposite of fragile. The 60% Alfonso concentration, single Jerez factory, and thin float are real bounded risks, but a week of no news doesn't change their character; they still aren't the leveraged, account-wiping kind of fragility this lens worries about most.
Stanley Druckenmiller Bullish 54 No catalyst has landed this week: the stock drifted up 3% on no news, and the August 13, 2026 print is still three weeks out. The Q1 2026 net income acceleration to +18% still diverges from peer Emperador's earnings collapse, but confidence should sit slightly lower than last week simply because there's one less week of runway before the confirming (or disconfirming) data point.

Conferred call: Buy (5 bullish, 0 neutral, 0 bearish), unchanged from July 12, 2026. All five lenses still agree with the page's Recommendation, for the same reasons as last week (Graham and Burry lean on the balance sheet, Buffett and Taleb on the moat and low fragility, Druckenmiller on the still-unrealized re-rating). Checked against the standing rulebook ([[stock-trading-strategy-and-rules]]): the setup still lacks the "good catalyst plus good earnings plus momentum together" combination the rules favor, since the stock has gone nowhere for years and the next print (August 13, 2026) remains an open question rather than a confirmed catalyst. That still argues for a patient accumulate rather than a chase.

Shared flip trigger: three of five lenses (Buffett, Burry, Druckenmiller) separately flag the same event: a second consecutive year of operating margin compression, or confirmation that Cosco/Puregold related-party dealings are priced against KEEPR's minority shareholders.

Review history

Date Price Recommendation
July 10, 2026 1.86 Buy (deep value, real net cash; single-brand concentration and family control cap conviction)
July 12, 2026 1.86 Buy (deep value, real net cash; single-brand concentration and family control cap conviction)
July 19, 2026 1.92 Buy (no new data; price up 3%, still deep value; single-brand concentration and family control cap conviction)

Sources

Analysis, not financial advice.